Texas Subject | DIABETES

Type

Status

State	Bill	Status	Summary/Title	Last Action
TX	SB241	Pass	Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. [Detail][Text][Discuss]	2023-05-27 Effective on . . . . . . . . . . . . . . . September 1, 2024
TX	HB2529	Intro Sine Die	Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability. [Detail][Text][Discuss]	2023-05-01 To House Public Health Committee
TX	HB2891	Engross Sine Die	Relating to the use of glucagon medication on certain public and private school campuses. [Detail][Text][Discuss]	2023-04-27 To Senate Education Committee
TX	SB2535	Intro Sine Die	Relating to the use of prescription glucagon medication on public and private school campuses. [Detail][Text][Discuss]	2023-03-23 To Senate Education Committee
TX	HB3912	Intro Sine Die	Relating to the applicability of health benefit plan cost-sharing requirements for prescription insulin. [Detail][Text][Discuss]	2023-03-20 To House Health Care Reform, Select Committee

LegiScan Search

NY A08947 Establishes the retail worker safety act requiring retail worker employers...

IL SB2234 BUSINESS TRUTH IN LENDING ACT

OK HB3031 Revenue and taxation; motor fuel tax; Oklahoma ambulance districts; effective...

FL H0055 Tax Exemptions for Surviving Spouses of Quadriplegics

FL H0357 Special Observances

CA SB1083 Department of Homelessness Prevention, Outreach, and Support.

GA SB496 Ad Valorem Taxation of Property; extension of preferential assessment periods...

OR HB4133 Relating to wildfire; prescribing an effective date; providing for revenue...

FL S1600 Interstate Mobility

TN SB2503 AN ACT to amend Tennessee Code Annotated, Title 4; Section 8-50-103 and...